ID

42268

Description

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 19.03.2021 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS, a multi-center cohort study, has been created to get more in-depth knowledge about the epidemiology and clinical course of patients infected with SARS-CoV-2. Initiated by the ESCMID Emerging Infections Task Force (EITaF) and the German Infectious Disease Society, and supported by all German Centers for Health Research (DZG), LEOSS has developed into an international network of contributors. Via an integrative research approach with anonymous recruitment and collection of routine data in an open science context, LEOSS is building a uniform clinical dataset and providing real-time analyses. For more information feel free to explore https://leoss.net/. This document is for Apheresis therapy details. If a text field can't be filled out, note 'ND' (for not determined).

Lien

https://leoss.net

Mots-clés

Versions (2)
  1. 30/10/2020 30/10/2020 -
  2. 26/04/2021 26/04/2021 -
Détendeur de droits

LEOSS

Téléchargé le

26 avril 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

Anglais

Apheresis therapy details

1 Formulaires  
Type of apheresis therapy that was performed
Description

Type of apheresis therapy that was performed

Alias
UMLS CUI-1
C0005791
UMLS CUI-2
C0332307
Therapeutic plasma exchange
Description

Therapeutic plasma exchange

Type de données

boolean

Alias
UMLS CUI [1]
C0032113
CytoSorb® therapy
Description

CytoSorb® therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C3521106
UMLS CUI [1,2]
C0079189
Double Filtration Plasmapheresis (DFPP)
Description

Double Filtration Plasmapheresis (DFPP)

Type de données

boolean

Alias
UMLS CUI [1]
C5200809
Other type of apheresis therapy
Description

Other type of apheresis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0005791
UMLS CUI [1,3]
C0332307
Indicate other type of apheresis therapy
Description

Indicate other type of apharesis

Type de données

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0005791
UMLS CUI [1,3]
C0332307
UMLS CUI [1,4]
C1521902
Treatment initiated in disease phase
Description

Treatment initiated in disease phase

Alias
UMLS CUI-1
C0005791
UMLS CUI-2
C0457338
UMLS CUI-3
C1704686
Phase when apheresis therapy has started
Description

Indicate in which disease phase the apheresis therapy was started.

Type de données

integer

Alias
UMLS CUI [1,1]
C0005791
UMLS CUI [1,2]
C0457338
UMLS CUI [1,3]
C1704686
Treatment details
Description

Treatment details

Alias
UMLS CUI-1
C0005791
UMLS CUI-2
C0087111
UMLS CUI-3
C1522508
Quantity of the average plasma volume per treatment
Description

Indicate quantity of the average plasma volume per treatment (apheresis therapy).

Type de données

integer

Alias
UMLS CUI [1,1]
C0032127
UMLS CUI [1,2]
C1510992
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0005791
Overall number of treatments
Description

Please indicate the number of treatment sessions during the observational period

Type de données

text

Alias
UMLS CUI [1,1]
C0005791
UMLS CUI [1,2]
C0750480
Duration of treatment
Description

Please indicate the number of days when apheresis has been applied

Type de données

text

Unités de mesure
  • day
Alias
UMLS CUI [1,1]
C0005791
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0439810
day
Perceived therapeutic effect
Description

Indicate if the treating physician experience a therapeutic effect.

Type de données

integer

Alias
UMLS CUI [1,1]
C1710470
UMLS CUI [1,2]
C1527144
UMLS CUI [1,3]
C0005791
UMLS CUI [1,4]
C0022423
Is data entry for this section finished?
Description

Is data entry for this section finished?

Alias
UMLS CUI-1
C4684556
UMLS CUI-2
C1828479
UMLS CUI-3
C0205197
Is data entry for this section finished?
Description

Is data entry for this section finished?

Type de données

boolean

Alias
UMLS CUI [1,1]
C4684556
UMLS CUI [1,2]
C1828479
UMLS CUI [1,3]
C0205197
Retour au début de la page

Similar models

Apheresis therapy details

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Type of apheresis therapy that was performed
C0005791 (UMLS CUI-1)
C0332307 (UMLS CUI-2)
Therapeutic plasma exchange
Item
Therapeutic plasma exchange
boolean
C0032113 (UMLS CUI [1])
CytoSorb® therapy
Item
CytoSorb® therapy
boolean
C3521106 (UMLS CUI [1,1])
C0079189 (UMLS CUI [1,2])
Double Filtration Plasmapheresis (DFPP)
Item
Double Filtration Plasmapheresis (DFPP)
boolean
C5200809 (UMLS CUI [1])
Other type of apheresis
Item
Other type of apheresis therapy
boolean
C0205394 (UMLS CUI [1,1])
C0005791 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
Indicate other type of apharesis
Item
Indicate other type of apheresis therapy
text
C0205394 (UMLS CUI [1,1])
C0005791 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
Item Group
Treatment initiated in disease phase
C0005791 (UMLS CUI-1)
C0457338 (UMLS CUI-2)
C1704686 (UMLS CUI-3)
Item
Phase when apheresis therapy has started
integer
C0005791 (UMLS CUI [1,1])
C0457338 (UMLS CUI [1,2])
C1704686 (UMLS CUI [1,3])
AP_start
Code List
Phase when apheresis therapy has started
CL Item
Uncomplicated phase (1)
CL Item
Complicated phase (2)
CL Item
Critical Phase (3)
CL Item
Recovery Phase (4)
CL Item
Unknown (5)
Item Group
Treatment details
C0005791 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
C1522508 (UMLS CUI-3)
Item
Quantity of the average plasma volume per treatment
integer
C0032127 (UMLS CUI [1,1])
C1510992 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0005791 (UMLS CUI [1,4])
AP_quantity
Code List
Quantity of the average plasma volume per treatment
CL Item
30 - 44 ml/kg (1)
CL Item
45 - 60 ml/kg (2)
CL Item
> 60 ml/kg (3)
CL Item
Not done (4)
CL Item
Unknown (5)
Treatments count
Item
Overall number of treatments
text
C0005791 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
Duration of treatment
Item
Duration of treatment
text
C0005791 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0439810 (UMLS CUI [1,3])
Item
Perceived therapeutic effect
integer
C1710470 (UMLS CUI [1,1])
C1527144 (UMLS CUI [1,2])
C0005791 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])
AP_effect
Code List
Perceived therapeutic effect
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Is data entry for this section finished?
Item
Is data entry for this section finished?
boolean
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial